24 Suppl.: 335610 de Jong PT
Once I accomplished that, they would take fat from my inner and outer thighs, flanks, and arms
This month's Broker Brief breaks down: - Why up to 65% of GLP-1 users discontinue within a year, and why that turns coverage into a sunk cost for employers - What oral GLP-1s like Lilly's Foundayo mean for demand, when most plans still have eligibility rules written for injectables only - How fast a PBM formulary decision can move, using this year's Zepbound to Wegovy switch and back as the case in point - Why 38% of employers already tie GLP-1 coverage to participation in a lifestyle or behavioral program If you're advising employers on GLP-1 coverage, this is where the conversation is heading
C., Krishnappa, D., Adkisson, W
Or you might get a lobectomy (removal of one of your thyroid lobes if just one is cancerous)
The other side: A CVS Caremark spokesperson told Bloomberg Law the lawsuit is "without merit." "Well defend ourselves vigorously against those claims," the spokesperson said